Dawn Health Secures EURm 11.5 to Scale Platform & Product Suite for Next-Gen Pharma Digital Health Solutions

Group 1 - Dawn Health has secured EUR 11.5 million in funding from existing investors to scale its platform and product suite for next-generation pharmaceutical digital health solutions [1] - The company has developed a platform tailored for the pharmaceutical industry, which has been adopted by major players like Merck and Novartis [2] - The Dawn Platform enhances patient care and outcomes through advanced capabilities in AI, data analytics, and clinical integrations, supporting therapy companions and disease management programs [3] Group 2 - The CEO of Dawn Health emphasized the ambition to lead in digital health and improve patient lives globally, with the new funding aimed at expanding market reach [4] - Since a major investment in December 2021, Dawn Health has significantly increased its revenue and workforce, now employing over 100 people [5] - Dawn Health specializes in Software as a Medical Device (SaMD) and Digital Therapeutics (DTx), focusing on chronic conditions and patient-centric solutions [6]